Samuel Meadema, MD
Otolaryngology · Danville, VANPI 1649225764
Payments from drug & device makers
Across 114 payments — averaging $20.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$628
- Sanofi$464
- Kaleo, Inc.$280
- Optinose US, Inc.$198
- GSK$197
- Aerin Medical Inc.$129
- plus $393 from 8 others
What the payments were for
- Food & beverage$2,23998%
- Education$492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 26 | $628 |
| Sanofi | 25 | $464 |
| Kaleo, Inc. | 18 | $280 |
| Optinose US, Inc. | 14 | $198 |
| GSK | 10 | $197 |
| Aerin Medical Inc. | 5 | $129 |
| Stryker | 6 | $105 |
| Inspire Medical Systems, Inc. | 3 | $102 |
| Olympus America Inc. | 1 | $69 |
| Novartis | 2 | $41 |
| Amgen | 1 | $29 |
| Phadia US Inc. | 1 | $18 |
| Osiris Therapeutics Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$2,288 in reported general payments places this provider in the 60th percentile of 241 otolaryngology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levocetirizine Dihydrochloride | 423 | $5,782 |
| Pantoprazole Sodium | 307 | $5,439 |
| Azelastine Hcl | 130 | $3,137 |
| Esomeprazole Magnesium | 51 | $2,788 |
| Epinephrine | 12 | $2,516 |
| Ipratropium Bromide | 78 | $2,289 |
| Omeprazole | 191 | $1,884 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 13 | $1,866 |
| Amitriptyline Hcl | 75 | $859 |
| Lansoprazole | 31 | $834 |
| Clarithromycin | 14 | $762 |
| Clotrimazole | 27 | $750 |
| Montelukast Sodium | 93 | $744 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 14 | $720 |
| Mometasone Furoate | 50 | $644 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Danville
- Laurence OhalloranAnnandale$2.9M
- Joseph HanNorfolk$2.9M
- Ryan NordRichmond$482K
- Paul LenkowskiRoanoke$282K
- Nipun ChhabraLeesburg$178K
- Kent LamNorfolk$143K
- Charles GrossCharlottesville$91K
- Spencer PayneCharlottesville$65K
- Aaron PrussinBlacksburg$55K
- Daniel CoelhoRichmond$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.